| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.24B | 5.44B | 5.38B | 3.71B | 2.95B |
| Gross Profit | 717.06M | 4.56B | 1.50B | 977.00M | 714.80M |
| EBITDA | 717.06M | 1.10B | 1.16B | 747.00M | 676.80M |
| Net Income | 356.63M | 307.00M | 381.00M | 232.00M | 263.00M |
Balance Sheet | |||||
| Total Assets | 10.73B | 10.55B | 11.13B | 11.92B | 4.32B |
| Cash, Cash Equivalents and Short-Term Investments | 1.73B | 911.00M | 1.56B | 2.09B | 597.90M |
| Total Debt | 4.56B | 4.11B | 4.73B | 5.40B | 1.93B |
| Total Liabilities | 6.65B | 6.33B | 7.04B | 7.82B | 3.06B |
| Stockholders Equity | 4.09B | 4.23B | 4.09B | 4.10B | 1.26B |
Cash Flow | |||||
| Free Cash Flow | 583.51M | 463.00M | 526.00M | 410.00M | 403.30M |
| Operating Cash Flow | 741.34M | 678.00M | 737.00M | 600.00M | 563.20M |
| Investing Cash Flow | 15.93M | -373.00M | -416.00M | -1.20B | -441.10M |
| Financing Cash Flow | 20.49M | -752.00M | -361.00M | 1.32B | -417.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £3.13B | 19.41 | 16.69% | 1.27% | 0.84% | -62.73% | |
76 Outperform | £2.19B | 13.52 | 20.62% | 2.58% | 11.42% | -17.18% | |
65 Neutral | £12.06B | 31.67 | 5.93% | 1.68% | -1.58% | -34.64% | |
65 Neutral | £5.60B | 21.21 | 31.07% | 3.44% | 1.14% | 17.74% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | £501.70M | 14.60 | 12.46% | 3.18% | 6.55% | 18.44% | |
54 Neutral | £350.53M | 275.23 | 0.58% | 2.31% | 6.90% | 145.00% |
Rentokil Initial reported 2025 revenue of $6.91bn, up 3.8% at constant currency, with group organic revenue growth improving to 3.5% in the second half and adjusted operating profit rising 5.4% as cost discipline and efficiency measures took hold. Free cash flow rose 24.5% to $615m, cash conversion reached 98%, net debt fell to 2.6 times EBITDA, and the dividend was raised 3%, although additional provisions for termite damage claims weighed on statutory profits.
In North America, pest control organic growth strengthened quarter by quarter, supported by a revamped marketing strategy, expansion of over 150 satellite branches, tighter pricing and improved customer and colleague retention, while an expanded multi-brand approach will see about 30 brands and roughly 800 branches retained to deepen local market penetration. Management said its efficiency programme, including shared services, outsourcing and digital tools, is on track to deliver about $100m of annual cost savings and lift the North American operating margin above 20% by 2027, reinforcing the group’s competitive position in a sector expected to see robust growth despite near-term macro and geopolitical uncertainties.
The most recent analyst rating on (GB:RTO) stock is a Hold with a £465.00 price target. To see the full list of analyst forecasts on Rentokil Initial stock, see the GB:RTO Stock Forecast page.
Rentokil Initial plc has announced that Board Chair Richard Solomons plans to retire once a successor is appointed, triggering a formal chair succession process at the London- and New York-listed services group. The search for a new chair is being led by Senior Independent Director John Pettigrew with support from the Nomination Committee, as the board emphasizes adherence to UK corporate governance standards and a smooth leadership transition.
Solomons, who has chaired the company since 2019, will remain in post until the new chair assumes responsibilities, providing continuity at a time of ongoing strategic execution for the global pest control and hygiene provider. The board has publicly thanked him for his leadership and signalled that a further announcement will follow once the appointment is finalized, indicating that investors and other stakeholders can expect formal confirmation of the company’s next chair in due course.
The most recent analyst rating on (GB:RTO) stock is a Hold with a £465.00 price target. To see the full list of analyst forecasts on Rentokil Initial stock, see the GB:RTO Stock Forecast page.
Rentokil Initial has announced that its Chief Financial Officer, Paul Edgecliffe-Johnson, has been appointed as a Non-Executive Director to the Board of Watches of Switzerland Group PLC, which is listed on the London Stock Exchange. The move underscores the cross-industry demand for senior financial and governance expertise, and may broaden Rentokil Initial’s leadership exposure and external board experience without altering its core operational responsibilities.
The company disclosed the appointment in line with regulatory requirements for director changes under the UK Listing Rules. Investors and stakeholders are likely to view the additional board role as an expansion of the CFO’s governance portfolio, while formal transparency around the appointment reflects ongoing compliance with market disclosure standards.
The most recent analyst rating on (GB:RTO) stock is a Buy with a £540.00 price target. To see the full list of analyst forecasts on Rentokil Initial stock, see the GB:RTO Stock Forecast page.
Rentokil Initial has announced the early redemption of its €500 million 0.875% senior unsecured guaranteed notes, originally due on 30 May 2026, with full repayment scheduled for 2 March 2026 at par plus accrued interest. Following redemption, the notes will be cancelled and delisted from the London Stock Exchange, simplifying the company’s capital structure and potentially reducing financing costs ahead of the original maturity.
The move underscores Rentokil Initial’s active management of its debt profile and balance sheet flexibility, which may be viewed positively by bondholders and equity investors monitoring its leverage and refinancing risk. The cancellation and delisting of the notes remove this particular instrument from trading, narrowing the company’s outstanding listed debt instruments while leaving its broader operations in pest control and hygiene services unaffected.
The most recent analyst rating on (GB:RTO) stock is a Buy with a £540.00 price target. To see the full list of analyst forecasts on Rentokil Initial stock, see the GB:RTO Stock Forecast page.
Rentokil Initial plc has appointed US executive Mike Duffy as its new Chief Executive and Executive Director, effective 16 March 2026, with a transition period beginning when he joins as CEO Designate on 16 February 2026. Duffy, who will be based in North America, brings over 25 years of experience leading large US B2B and B2C businesses, most recently as CEO of logistics group OnTrac and previously FleetPride and C&S Wholesale Grocers, and is regarded by the board as well placed to drive multi-site operational efficiency, profitable growth and technology-led transformation across Rentokil’s global service network. He succeeds long-serving CEO Andy Ransom, credited with building Rentokil into the world’s largest pest control business and expanding its hygiene and wellbeing platform, and will be compensated in line with the company’s remuneration policy, including replacement awards for incentives forfeited on leaving his current role. The leadership change underscores Rentokil’s strategic focus on its North American market and on further operational and financial improvement, with Ransom and CFO Paul Edgecliffe-Johnson set to update the market on full-year 2025 results shortly before the handover in March 2026.
The most recent analyst rating on (GB:RTO) stock is a Buy with a £520.00 price target. To see the full list of analyst forecasts on Rentokil Initial stock, see the GB:RTO Stock Forecast page.
Rentokil Initial plc disclosed that the Samuel J. Mitchell, Jr. Revocable Trust, a person closely associated with non-executive director Samuel Mitchell, purchased 30 American Depositary Shares of the company on 11 August 2025 at a price of $25.12 per ADS on the New York Stock Exchange, bringing Mitchell’s total beneficial holding to 120 ADSs. The transaction, reported under UK Market Abuse Regulation requirements, slightly increases board-related insider ownership and provides investors with additional transparency on director-affiliated share dealings, though the size of the trade is not material to the company’s overall capital structure.
The most recent analyst rating on (GB:RTO) stock is a Buy with a £510.00 price target. To see the full list of analyst forecasts on Rentokil Initial stock, see the GB:RTO Stock Forecast page.